Following a mini-stroke patients are at a heightened risk for a stroke.  Many take precautions to make sure that doesn't happen. However, some methods for stroke prevention are not proving to be effective protection.

Hypertension, diabetes and smoking  are known to increase your chances for stroke. A new study shows they can also be factors in developing cognitive problems later in life, even among patients who have never experienced a stroke.

U.S. Food and Drug Administration officials have announced that cholesterol-lowering drug fenofibric acid (Trilipix) might not lower a patient's risk of having a heart attack or stroke.

U.S. Food and Drug Administration officials have given the green light to anti-clotting drug Xarelto (rivaroxaban) to reduce the risk of stroke in patients with a common heart arrhythmia called atrial fibrillation.

After a stroke some patients may find it easier to quit smoking. There may be a good reason for that. Smokers who intended to stop prior to the stroke and those who have a particular area of their brain damaged by stroke are more likely to quit.

After a stroke it's common to suffer secondary damage in the days or weeks following the initial brain attack. A protein may be the key to preventing later damage to the brain.

Kidney disease patients face a high risk of heart-related events like stroke. As such, patients need ways to protect against potentially deadly problems. Now, health advisors are backing a drug that does just that.

For stroke patients who have dementia the outcome may be worse. Dementia patients who have a stroke are more likely to suffer disability and less likely to return home.

For patients who have suffered a mini stroke, a specialized hospital-based care team featuring nurse-led counseling may be the way to improve health while reducing the risk of future vascular events.

In an effort to highlight awareness and urge the public to lower their stroke risk today on World Stroke Day, the American Stroke Association is urging Americans to test their knowledge of the potentially deadly condition.